Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Status:
Completed
Trial end date:
2019-10-28
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, tolerability and activity of a once-weekly
regimen of carfilzomib in combination with lenalidomide and dexamethasone for the treatment
of multiple myeloma.